Research programme: inhaled broad-spectrum antibacterial therapy - Ology Bioservices

Drug Profile

Research programme: inhaled broad-spectrum antibacterial therapy - Ology Bioservices

Alternative Names: Gentamicin dry-powder inhalation - Ology Bioservices; NanoGENT

Latest Information Update: 06 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nanotherapeutics
  • Developer Ology Bioservices
  • Class
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Pneumonic plague; Respiratory tract infections; Tuberculosis; Tularaemia

Most Recent Events

  • 02 Oct 2017 Nanotherapeutics is now called Ology Bioservices
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Pneumonic-plague in USA (Inhalation, Powder)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Respiratory-tract-infections in USA (Inhalation, Powder)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top